Health Care · Biotechnology
AskBio news and milestones
AskBio: 15 headlines on record, 1 headline in the last 90 days. Its story counts 2 milestones.
Data updated Nov 18, 2026 · Back to the company report
15Headlines
1In 90 days
2Milestones
Headlines
Aug 292026
Blog
Phase 2 GenePHIT trial successfully randomized and completed enrollment of one of the largest gene therapy trials conducted in heart failure to date, with more than 170 participa…
May 112026
Blog
AB-1009, an adeno-associated virus (AAV) investigational gene therapy, is being evaluated for the treatment of late-onset Pompe disease (LOPD) in the PROGRESS-GT LOPD trial AskBi…
May 72026
News · YahooFinance
Durham, N.C., May 07, 2026 (GLOBE NEWSWIRE) -- Three oral and 3 poster presentations demonstrate progress of AskBio's gene therapy research, development, and manufacturing activi…
Apr 202026
Blog
Not intended for UK Media Ametefgene parvec (AB-1005) manufactured at Viralgen commercial manufacturing facility with next-generation process to deliver high-purity product with…
Apr 12026
Blog
Final participant randomized in the GenePHIT Phase 2 clinical trial assessing safety and efficacy of AB-1002 for adults with non-ischemic cardiomyopathy and New York Heart Associ…
Jan 82026
Blog
AB-1009 program advances to Phase 1/Phase 2; clinical trial initiated in the United States Therapy granted United States Food and Drug Administration (FDA) Fast Track and Orphan…
Dec 9, 20252025
Blog
Product designation supports development of innovative investigational gene therapies for Parkinson's disease (PD) and congestive heart failure (CHF) Not intended for UK Media Be…
Oct 21, 20252025
Blog
First-in-human trial of investigational gene therapy AB-1002 designed to evaluate safety and preliminary efficacy in participants with New York Heart Association (NYHA) Class III…
Oct 10, 20252025
Blog
Data from first cohort of five participants suggest an acceptable safety profile for AB-1003 in participants with limb-girdle muscular dystrophy (LGMD) 2I/R9, with no dose-limiti…
Oct 2, 20252025
Blog
One oral presentation and five poster presentations will highlight exciting progress in AskBio's pipeline and advancements in the company's manufacturing technologies Research Tr…
Apr 16, 20242024
News · YahooFinance
Berlin, Germany, and Research Triangle Park, NC, USA, April 16, 2024 (GLOBE NEWSWIRE) -- Not intended for UK Media AB-1005 (also known as AAV2-GDNF), an investigational gene ther…
Oct 26, 20202020
News · PE Hub
Bayer AG has agreed to acquire AskBio, a biopharmaceutical company.
Apr 11, 20192019
Press release · businesswire.com
Sources: the outlets named on each headline, each story once
Milestones
Each milestone is dated by its source: registers, filings, the press
How to cite
AskBio, News. Alion, Nov 18, 2026. https://alion.io/company/askbio/news
